George Phillips is a patent attorney with experience preparing hundreds of freedom to operate opinions and patent applications related to biomedical and mechanical devices. He manages a number of global patent portfolios and regularly counsels clients on post-grant issues including patent invalidity and noninfringement. He also has experience advising on intellectual property aspects of corporate transactions including portfolio analysis, market clearance, licensing, and other technology aspects of M&A transactions.
George has extensive technical knowledge handling matters related to medical and automotive technology. He advised Cardinal Health on intellectual property issues related to its acquisition of Johnson & Johnson's Cordis business, a global manufacturer of medical devices. He has prepared invalidity contentions in defense of a patent infringement action regarding stent technology. He also manages a number of worldwide patent portfolios in the autonomous vehicle, biomedical, and petroleum industries including preparation and prosecution of patent applications.
Prior to joining Jones Day, George worked for two years at the U.S. Patent and Trademark Office as a patent examiner where he handled medical device patent applications.
Cardinal Health acquires Cordis for $1.9 billion
Jones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
Sewoon obtains dismissal of patent infringement action regarding stent technology
Jones Day successfully defended Sewoon Medical Co., Ltd., Standard Sci-Tech Inc., and EndoChoice, Inc. in a patent infringement action regarding stent technology.
Taewoong Medical resolves patent infringement dispute over stent technology
Jones Day successfully defended Taewoong Medical Co., Ltd. in a patent infringement action regarding stent technology.
Cardinal Health acquires The Harvard Drug Group for $1.115 billion
Jones Day advised Cardinal Health in its acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, over-the-counter medications, and related products to retail, institutional, and alternate care customers from Court Square Capital Partners for $1.115 billion.
International Automotive Components Group completes refinancing of Senior Secured Notes
Jones Day advised International Automotive Components Group, S.A., a leading global supplier of automotive components and systems, in connection with the issuance of $215 million of Senior Secured Notes due 2023 to Gamut Capital Management, L.P. in a private placement.
Randstad acquires Monster for $429 million
Jones Day advised Randstad Holding nv (AMS: RAND), a leading human resources services provider, in the acquisition of Monster Worldwide, Inc. (NYSE: MWW).
Hill-Rom acquires Mortara Instrument for $330 million
Jones Day advised Hill-Rom Holdings, Inc. in its acquisition of Mortara Instrument, Inc., a privately held leader in diagnostic cardiology and patient monitoring solutions, technologies, and devices, for $330 million in cash.
XIO acquires Lumenis for approximately $510 million, $14 per share, in cash
Jones Day advised XIO Group in its acquisition of Lumenis Ltd., the world's largest energy-based medical company for surgical, ophthalmology, and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of approximately $510 million.
Cardinal Health acquires rights to Lymphoseek® from Navidea Biopharmaceuticals
Jones Day advised Cardinal Health in its acquisition of Navidea Biopharmaceuticals' rights to Lymphoseek® in North America for lymphatic mapping, lymph node biopsy, and the diagnosis of metastatic spread to lymph nodes for the staging of cancer.
naviHealth acquires RightCare Solutions
Jones Day represented Cardinal Health and its subsidiary, naviHealth, Inc., in connection with the acquisition of RightCare Solutions, Inc., a health care decision support software service provider specializing in hospital discharge planning software and readmissions management.
Hyster-Yale acquires Nuvera Fuel Cells
Jones Day advised Hyster-Yale Materials Handling, Inc. in the acquisition of Nuvera Fuel Cells, Inc. by its operating company, NACCO Materials Handling Group, Inc.
- February 2016PGR Eligibility for Patents Issuing from Pre-AIA Examined Applications, PTAB Litigation Blog
- June 20152015 Patent Reform: Amendments to H.R. 9 and S. 1137
- May 20152015 Patent Reform: Protecting American Talent and Entrepreneurship Act of 2015 (S. 1137)
- March 20152015 Patent Reform: Innovation Act (H.R. 9) and STRONG Patents Act (S. 632)
- April 11, 2017Interviewing USPTO Examiners, and Understanding USPTO Workings Including the Count System
- July 29, 2015Design Patents Awakening from their Beauty Sleep: An EU and US Overview
- University of Maryland (J.D. cum laude 2010; Associate Editor, Journal of Business and Technology Law; Vice President, Maryland Intellectual Property Law Society); New Jersey Institute of Technology, Albert Dorman Honors College (B.S. in Biomedical Engineering summa cum laude 2007; Tau Beta Pi)
- New York, New Jersey, and registered to practice before the U.S. Patent and Trademark Office
- Patent Examiner, U.S. Patent and Trademark Office (2010-2012)